
ASCO/LinkedIn
Jan 24, 2025, 01:44
New guideline update on Neoadjuvant Chemotherapy for Ovarian Cancer – ASCO
ASCO shared a post on LinkedIn:
“Check out our new guideline update on Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer. These guideline recommendations suggest that patients with suspected stage III-IV EO should be evaluated by a gynecologic oncologist including CA-125, CT of the abdomen and pelvis, and chest imaging.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 10, 2025, 09:18
Feb 10, 2025, 08:06
Feb 10, 2025, 07:48
Feb 10, 2025, 07:41
Feb 10, 2025, 07:38
Feb 10, 2025, 06:49